SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934
|Filed by the Registrant x|
|Filed by a Party other than the Registrant o|
|Check the appropriate box:|
|¨||Preliminary Proxy Statement|
|o||Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))|
|o||Definitive Proxy Statement|
|x||Definitive Additional Materials|
|o||Soliciting Material under §240.14a-12|
|(Name of Registrant as Specified In Its Charter)|
|(Name of Person(s) Filing Proxy Statement, if other than the Registrant)|
|Payment of Filing Fee (Check the appropriate box):|
|x||No fee required.|
|o||Fee paid previously with preliminary materials.|
|o||Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11.|
Appointment of Proxy Solicitor
Ocugen, Inc. (the “Company”) has engaged Innisfree M&A Incorporated (“Innisfree”) to act as its proxy solicitor in connection with the Company’s 2023 Annual Meeting of Shareholders. The Company will pay Innisfree a fee of $15,000, plus $5.50 per call made or received from individual retail investors, in addition to reasonable out of pocket expenses, for these services, and the Company will bear the entire cost associated with these services.
May 8, 2023
We have previously sent you proxy material for Ocugen, Inc.’s Annual Meeting of Shareholders taking place on June 9, 2023. Your Board of Directors unanimously recommends that shareholders vote “FOR ALL” directors nominated for election to the Board and “FOR” the other two agenda items.
Your vote is important, no matter how many or how few shares you may own. If you have not already done so, please vote TODAY via the Internet, by telephone, or by returning the enclosed proxy card in the postage-paid envelope provided.
Chairman of the Board, CEO and Co-Founder